SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results

Sioux Falls, SD , March 29, 2024 -- SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results March 29, 2024 SAB-142 Phase 1 trial on track for data release during 2024 ...

Related Keywords

New York ,United States ,Andrew Moin ,Katie Ellias ,Samuelj Reich ,Erick Lucera ,Michaelg King Jr ,Rd Fund ,Twitter ,Biotherapeutics Inc ,Exchange Commission ,Globenewswire Inc ,Linkedin ,Nasdaq ,Sioux Falls ,Reports Full Year ,Recent Corporate Developments ,Chief Financial ,Leadership Committee ,New York City Chapter ,Managing Partner ,Veralox Therapeutics ,Chief Financial Officer ,Virtual Conference ,Private Securities Litigation Reform Act ,Investor Relations ,Markets ,